SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-122346
Filing Date
2019-04-26
Accepted
2019-04-26 16:09:55
Documents
7
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d711750ddefa14a.htm DEFA14A 41337
2 GRAPHIC g711750g22q82.jpg GRAPHIC 9511
3 GRAPHIC g711750g39a28.jpg GRAPHIC 9370
4 GRAPHIC g711750g42i87.jpg GRAPHIC 8387
5 GRAPHIC g711750g58u06.jpg GRAPHIC 8516
6 GRAPHIC g711750g91z09.jpg GRAPHIC 8517
7 GRAPHIC g711750g93g60.jpg GRAPHIC 8480
  Complete submission text file 0001193125-19-122346.txt   83686
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36500 | Film No.: 19771858
SIC: 2834 Pharmaceutical Preparations